Offer - Urjas Oil for just ₹ 1
Ibugesic Asp is a prescription drug, available for use as Tablet. Secondary and off-label uses of Ibugesic Asp have also been mentioned below.
The correct dosage of Ibugesic Asp depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Ibugesic Asp include Nausea or vomiting, Diarrhoea, Dizziness. Such side effects of Ibugesic Asp normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Ibugesic Asp has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Ibugesic Asp's effects on the liver, heart and kidney are discussed below in the Ibugesic Asp related warnings section.
Ibugesic Asp can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Ibugesic Asp in conditions like Kidney Disease, Asthma, Heart Attack.
Besides this, Ibugesic Asp may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Ibugesic Asp is not safe while driving, and is is not addictive in nature.
Ibugesic Asp is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Ibugesic Asp safe for pregnant women?
Ibugesic ASP should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Ibugesic Asp safe during breastfeeding?
Ibugesic ASP may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Ibugesic Asp on the Kidneys?
There may be some adverse effects on kidney after taking Ibugesic ASP. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Ibugesic Asp on the Liver?
There may be an adverse effect on the liver after taking Ibugesic ASP. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Ibugesic Asp on the Heart?
You may experience side effects on your heart after taking Ibugesic ASP. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Ibugesic Asp should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Ibugesic Asp unless your doctor advises you to do so -
Is this Ibugesic Asp habit forming or addictive?
Forming a habit of Ibugesic Asp has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Ibugesic Asp as you may feel sleepy.
Is it safe?
Ibugesic Asp is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Ibugesic Asp is not used to treat mental disorders.
Interaction between Food and Ibugesic Asp
Due to the absence of research, it is difficult to say how Ibugesic Asp and food will interact.
Interaction between Alcohol and Ibugesic Asp
Due to lack of research, there is no information about the side effects of taking Ibugesic Asp with alcohol.
No, you can not take Ibugesic ASP with the antihypertensive drugs because it reduces the effects of the antihypertensive medicine. However, if you experience any sign and symptoms of an adverse reaction after consuming medicine, please inform the doctor and follow his/her instructions.
No, Ibugesic ASP is not used for treating stomach pain. The stomach pain could be due to some underlying medical condition which may require medical attention. If the pain does not subside within 1 day. Please consult your doctor without any further delay.
No, Ibugesic ASP cannot be taken with ibuprofen. It may increase the chances of side effects if taken together. However, if you experience any undesirable effects after consuming medicine, please inform the doctor and follow his/her instructions.
No, Ibugesic ASP is not a muscle relaxant. It is a painkiller belongs to the class of medications called nonsteroidal anti-inflammatory drugs. Combination of Ibugesic ASP and the muscle relaxant are also available in the market which used to enhance the pain-relieving capacity of this medicine.
Ibugesic ASP is a pain relieving medicine. One should take as long as he/she has been recommended to take. However, sometimes even after symptomatic relief your doctor may ask you to continue with medication to reduce inflammations in the body.
This medicine data has been created by -
References
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
Package Leaflet Information For The User [Internet]: Aceclofenac 100 mg film-coated Tablets. Accord Healthcare Limited
Package leaflet Information for the patient [Internet]: Paracetamol Tablets 500mg. actavis
Shivani Bhagat*, Monika Agarwal, Vandana Roy [Internet]: Serratiopeptidase: A systematic review of the existing evidence. International Journal of Surgery 11 (2013) 209e217
